Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
09/2002
09/17/2002CA2038667C Process for the preparation of mannosyl teicoplanin derivatives and mannosyl teicoplanin aglycone
09/12/2002WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
09/12/2002WO2002069948A1 Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders
09/12/2002WO2001096334A3 Heteroarylalkanoic acids as integrin receptor antagonists
09/12/2002US20020128471 Useful for treating cellular hyperproliferation
09/12/2002US20020128263 Treatment or prevention of mGluR5 receptor mediated disorders.
09/12/2002US20020127248 Using rapamycin compound for therapy and prophylaxis of neointimal proliferation and thickening
09/12/2002CA2439581A1 Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders
09/12/2002CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
09/11/2002EP0763036B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
09/11/2002CN1368848A Heterocyclic spiro compounds as pesticides
09/11/2002CN1090634C Pro-drugs and counterparts of camptothecin, their application as medicines
09/11/2002CN1090631C Heterocyclic compounds, preparation process thereof and medicinal composition containing same
09/10/2002US6448443 Synthesis of combinatorial libraries of compounds reminiscent of natural products
09/10/2002US6448397 Treating central nervous system diseases with modulation of 5-ht activity; adrenergic, dopaminergic, and serotonergic neurotransmitters; psychosis, paraphrenia, depression, mania, schizophrenia, anxiety, migraine headache, drug addiction
09/10/2002US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors
09/10/2002US6448283 Fused pyrrolocarbazoles; hearing loss and loss of the sense of balance
09/10/2002US6448266 Substituted cyclobutylamine derivatives
09/10/2002US6448247 Tachykinin receptor antagonist; especially to the receptors for substance p (which receptors are generally referred to as ?neurokinin 1 receptors?)
09/10/2002CA2240946C Isoxazoline, isothiazoline and pyrazoline factor xa inhibitors
09/10/2002CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase
09/06/2002WO2002068427A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds
09/06/2002WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2002WO2002067675A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
09/06/2002WO2002040000A3 Use of cci-779 as an antineoplastic agent
09/06/2002WO2002038563A3 Condensed pyrazindione derivatives as pde inhibitors
09/06/2002CA2434727A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds
09/06/2002CA2424768A1 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
09/05/2002US20020123626 Treating methyl-substituted, benzimidazolone-fused dioxazine pigment with a solvent selected from N-methylpyrrolidone, c1-c20 alcohol, 1,2,4-trichlorobenzene, trifluoroacetic acid, dichloroacetic acid or mixture at a temp 0-250 degree C.
09/05/2002US20020123505 Stents, catheters, arterio-venous grafts, by-pass grafts and drug delivery ballons with surface coating containing a rapamycin derivative having a tetrazole group
09/05/2002US20020123497 For therapy of cancer, neurofibromin benign proliferative disorder; blindness related to retinal vascularization; infections from hepatitis delta and related viruses; prophylaxis of restenosis; polycystic kidney disease
09/05/2002DE10109856A1 Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus
09/04/2002EP1235831A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
09/04/2002EP1235823A1 H-annellated benzo f]chromenes
09/04/2002EP0724587B1 Ring-expanded nucleosides and nucleotides
09/04/2002CN1367787A Water soluble SDZ-RAD esters
09/04/2002CN1367169A Substituted 6,6-Hetero-dicycloderivative
09/03/2002US6444812 Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazoles
08/2002
08/29/2002WO2002066484A1 Isoxazoline derivatives as anti-depressants
08/29/2002WO2002066479A1 Novel isoindole derivatives
08/29/2002WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066468A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066418A2 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
08/29/2002WO2002066019A2 Cancer treatment
08/29/2002WO2002028867A3 Ethers of 7-desmethylrapamycin for use in immunosuppression
08/29/2002WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists
08/29/2002US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
08/29/2002US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
08/29/2002US20020119150 Administering an effective amount of a CD40:CD154 binding interrupter to primate graft recipient for therapy of rejection of tissue graft
08/29/2002CA2438504A1 Treatment of solid tumours with rapamycin derivatives
08/29/2002CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2438316A1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/28/2002EP1233956A1 Bryostatin analogues, synthetic methods and uses
08/28/2002EP0918777B1 SELECTED DERIVATIVES OF K-252a
08/28/2002EP0892804B1 Isoxazolidine derivatives
08/27/2002US6441172 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
08/27/2002US6441163 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
08/27/2002US6441019 Cyclocarbamate and cyclic amide derivatives
08/27/2002US6441017 Inhibitors of prenyl-protein transferase
08/27/2002US6440992 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
08/27/2002US6440991 Ethers of 7-desmethlrapamycin
08/27/2002US6440990 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
08/27/2002US6440960 An oxygen or sulfure or sulfure oxide or dioxide containing tricyclic compouund useful for treating the disorder manifesting hypersecretion of corticotropin releasing factor
08/27/2002US6440458 Solid solution of tacrolimus or hydrate and hydroxypropyl cellulose
08/22/2002WO2002064680A1 Acid pigment dispersants and pigment preparations
08/22/2002WO2002064599A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
08/22/2002WO2002064589A1 Laulimalide derivatives
08/22/2002WO2002064574A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
08/22/2002WO2002064145A1 Thioxazinoquinolones useful for the treatment of viral infections
08/22/2002WO2002064128A1 Treatment of diseases characterized by excessive or insufficient cell death
08/22/2002WO2002032893A3 Piperidine compounds as anti-allergic
08/22/2002US20020115854 Thrombin or factor Xa inhibitors
08/22/2002US20020115706 Treatment of both hearing loss and loss of the sense of balance by administering a a fused pyrrolocarbazole derivative
08/22/2002US20020115675 Treating particularly tumoral diseases, diseases of the lungs and respiratory tract.
08/22/2002US20020115566 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof
08/22/2002CA2436371A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
08/22/2002CA2436195A1 Laulimalide derivatives
08/22/2002CA2405532A1 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
08/21/2002EP1231984A1 Phorboxazole derivatives for treating cancer
08/20/2002US6437151 Fermentation; culture product
08/20/2002US6436962 Alpha 1a adrenergic receptor antagonists; relief from benign prostatic hyperplasia by less hindered urine flow by relaxing smooth muscle tissue; with a testosterone 5-alpha reductase inhibitor, finasteride; acute and chronic relief
08/15/2002WO2002062804A1 Oxazolyl-pyrazole derivatives as kinase inhibitors
08/15/2002WO2002062796A1 Epindolidione pigments
08/15/2002WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors
08/15/2002WO2002062770A1 Isoxazoline derivative and herbicide comprising the same as active ingredient
08/15/2002WO2002062335A2 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
08/15/2002WO2002062301A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
08/15/2002WO2002062290A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
08/15/2002WO2002028866A3 Hydroxyesters of 7-desmethylrapamycin
08/15/2002WO2002026746A3 1-oxorapamycins
08/15/2002WO2001096307A3 Cycloalkyl alkanoic acids as integrin receptor antagonists
08/15/2002US20020111374 Estrogen receptor modulators
08/15/2002US20020111355 Antitumor agents; contraceptives
08/15/2002US20020111350 Aryl fused azapolycyclic compounds
08/15/2002CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors
08/15/2002CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails
08/14/2002EP1230245A2 Novel herbicides